StocksRunner logo
mail
search
 
menu
 
Apogee Therapeutics
$56.04
+0.61%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 

APGE Stock Analysis & IQ Rating | Apogee Therapeutics Inc.

 
 
 

APGE

 

Apogee Therapeutics Inc.

$56.04

 
+$0.34 | +0.61%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 63.5
 
 
MKT CAP
$ 3.73B
 
52W Low
$ 26.2
 
 
VOL
$ 857.41K
 
P/E Ratio
N/A
 
 
AVG VOL
$ 814.55K
 
RSI
67.26
 
 
TREND
Sideways
 
 
 

APGE Stock IQ

 
lock  Login to see Apogee Therapeutics Inc. (APGE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

APGE Target Price

 
 
 

Strengths

 

APGE Rewards

 Upgraded on attractively valued

APGE Rewards

 Outperform the market

APGE Rewards

 Earnings are forecast to grow

 
 

Chart

 
 

$39.61   (+41.48%)

$37.79   (+48.29%)

$37.79   (+48.29%)

$37.79   (+48.29%)

 
 
1year
6month
3month
1month
 

APGE Risk Level

 

APGE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
APGE Risk Level
LOW
HIGH
 

APGE Analysts Opinion

 

APGE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 

APGE Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

APGE Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

APGE Future Sentiment

 Outperform the market

APGE Future Sentiment

 Earnings are forecast to grow

 
 

APGE Analysts Opinion

APGE Analysts opinion is negative and it remained unchanged from the past 3 months

 

APGE Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

APGE Street Opinion 

APGE Street view is extremely bullish and have positive views on the near-term outlook

 

APGE Performance Sentiment

 
Sentiments overview associated with APGE events and the stock performance.
 
100%
0%
Positive
Negative
13 out of 13
events present
0 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$53.32
 
Resistance
Price
 
$38.22
 
 
Current Price Range
 
$56.94
 
 
Show methods +
 
 
 
APGE Latest Analysis +
 
 
FAQ About APGE Stock Insights
 

What is APGE current stock price?

What are APGE stock strengths?

What risks are associated with APGE stock?

When is APGE next earnings report?

What is APGE market cap and volume?

What is APGE's current Stock IQ?

Should I buy APGE stock right now?

Is APGE a Strong Buy right now?

What does a 'Strong Buy' rating mean for APGE?

What does a 'Strong Sell' rating mean for APGE?

What factors influence APGE's Stock IQ?

 
 
StocksRunner

Explore our APGE Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored APGE Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our APGE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
mail
 
 

APGE

 

Apogee Therapeutics Inc.

 
 

Current Price

 

$56.04

 
+$0.34 | +0.61%
 
 
52W High
$ 63.5
 
 
MKT CAP
$ 3.73B
 
52W Low
$ 26.2
 
 
VOL
$ 857.41K
 
P/E Ratio
N/A
 
 
AVG VOL
$ 814.55K
 
RSI
67.26
 
 
TREND
Sideways
 
 
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

APGE Rewards

 Upgraded on attractively valued

APGE Rewards

 Outperform the market

APGE Rewards

 Earnings are forecast to grow

 
 
 
 
 

APGE Stock IQ

 
lock  Login to unlock Apogee Therapeutics Inc. (APGE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$39.61   (+41.48%)

$37.79   (+48.29%)

$37.79   (+48.29%)

$37.79   (+48.29%)

 
 
1year
6month
3month
1month
 

APGE Analysts Opinion

 

APGE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 

APGE Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

APGE Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

APGE Future Sentiment

 Outperform the market

APGE Future Sentiment

 Earnings are forecast to grow

 
 

APGE Analysts Opinion

APGE Analysts opinion is negative and it remained unchanged from the past 3 months

 

APGE Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

APGE Street Opinion 

APGE Street view is extremely bullish and have positive views on the near-term outlook

 

APGE Risk Level

 

APGE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
APGE Risk Level
LOW
HIGH
 
APGE Performance Sentiment
 
Sentiments overview associated with APGE events and the stock performance.
 
100%
0%
Positive
Negative
13 out of 13
events present
0 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$53.32
 
Resistance
Price
 
$38.22
 
 
Current Price Range
 
$56.94
 
 
Show methods +
 
 
 
 
 
 
 

APGE Latest Analysis

 
 
 

Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 69.3%: Heres is How to Trade. The average of price targets set by Wall Street analysts indicates a potential upside of 69.3% in Apogee Therapeutics Inc. (APGE). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.

 

Today

$56.04 | +0.61%
 
Potential
Potential

Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect?. The consensus price target hints at a 72.5% upside potential for Apogee Therapeutics Inc. (APGE). While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

 

Tue Oct 14, 2025

$52.33 | -3.05%
 
Momentum
Potential

Apogee Therapeutics Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million. ) a clinical-stage biotechnology company advancing optimized novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&.I) markets today announced the closing of its previously announced underwritten public offering of 8048782 shares of its common stock including the full exerc

 

Fri Oct 10, 2025

$52.47 | -1.39%
 
Activity
Potential

Apogee Therapeutics Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million.

 

Fri Oct 10, 2025

$52.47 | -1.39%
 
Activity
 
 
 
 
 
StocksRunner

Discover APGE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of APGE. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our APGE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

APGE Stock trends

APGE Stock performance

APGE Stock analysis

APGE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

APGE Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
 
Post ×
 
0/666
joker
 
 
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing APGE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing APGE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.